Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma

This publication has 26 references indexed in Scilit:

• Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma
  Cancer, 2003
• Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
  Gastroenterology, 2003
• Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults
  Gut, 2001
• Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding
  New England Journal of Medicine, 2000
• Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis
  Experimental Cell Research, 1996
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
  Cell, 1995
• Acid-Reflux Disorders
  New England Journal of Medicine, 1994
• A New Questionnaire for Gastroesophageal Reflux Disease
  Mayo Clinic Proceedings, 1994
• Epidemiology and Natural History of Gastro-Oesophageal Reflux Disease
  Digestion, 1992
• The Histologic Spectrum of Barrett's Esophagus
  New England Journal of Medicine, 1976